Advanced search
Publication Cover
Hematology Volume 27, 2022 - Issue 1
Submit an article Journal homepage
10,584
Views
0
CrossRef citations to date
0
Altmetric
Research Article

An immune-related gene prognostic index for acute myeloid leukemia associated with regulatory T cells infiltration

Qiongni XieDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Zhongyuan TangDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Xiaolin LiangDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Zeyan ShiDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Yibin YaoDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Xiaoke HuangDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Shanhu ZhuDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Meiqing WuDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Jing LiDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
,
Weihua ZhaoDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaView further author information
&
Zhenfang LiuDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Key Laboratory of Hemotology, Education Department of Guangxi Zhuang Autonomous Region, Guangxi Medical University, Nanning, Guangxi530021, People’s Republic of ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1089-1101 | Published online: 14 Sep 2022

References

  • Fitzmaurice C, Abate D, Abbasi N, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5(12):1749–1768.
  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
  • Yan Y, Zhang L, Zuo Y, et al. Immune checkpoint blockade in cancer immunotherapy: mechanisms, clinical outcomes, and safety profiles of PD-1/PD-L1 inhibitors. Arch Immunol Ther Exp. 2020;68(6):1–15.
  • Williams P, Basu S, Garcia-Manero G, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125(9):1470–1481.
  • Shenghui Z, Yixiang H, Jianbo W, et al. Elevated frequencies of CD4+ CD25+ CD127lo regulatory T cells is associated to poor prognosis in patients with acute myeloid leukemia. Int J Cancer. 2011;129(6):1373–1381.
  • Stirewalt DL, Meshinchi S, Kopecky KJ, et al. Identification of genes with abnormal expression changes in acute myeloid leukemia. Genes Chromosom Cancer. 2008;47(1):8–20.
  • Metzeler KH, Hummel M, Bloomfield CD, et al. An 86-probe-set gene-expression signature predicts survival in cytogenetically normal acute myeloid leukemia. Blood, J Am Soc Hematol. 2008;112(10):4193–4201.
  • Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9(1):1–13.
  • Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33(1):1.
  • Jiang P, Gu S, Pan D, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550–1558.
  • Sander FE, Nilsson M, Rydström A, et al. Role of regulatory T cells in acute myeloid leukemia patients undergoing relapse-preventive immunotherapy. Cancer Immunol Immunother. 2017;66(11):1473–1484.
  • Zhao J, Wang L, Kong D, et al. Construction of novel DNA methylation-based prognostic model to predict survival in glioblastoma. J Comput Biol. 2020;27(5):718–728.
  • Yin H, Li Z, Chen J, et al. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis. J Cell Biochem. 2019;120(4):5232–5243.
  • Wang C, Xu J, Fu H, et al. TRIM 32 promotes cell proliferation and invasion by activating β-catenin signalling in gastric cancer. J Cell Mol Med. 2018;22(10):5020–5028.
  • Yang SH, Liu W, Peng J, et al. High expression of RhoBTB3 predicts favorable chemotherapy outcomes in non-M3 acute myeloid leukemia. J Cancer. 2021;12(14):4229.
  • Brandl K, Tomisato W, Li X, et al. Yip1 domain family, member 6 (Yipf6) mutation induces spontaneous intestinal inflammation in mice. Proc Natl Acad Sci USA. 2012;109(31):12650–12655.
  • Bowman RL, Busque L, Levine RL. Clonal hematopoiesis and evolution to hematopoietic malignancies. Cell Stem Cell. 2018;22(2):157–170.
  • Bullinger L, Döhner K, Döhner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35(9):934–946.
  • Corthay A. How do regulatory T cells work?. Scand J Immunol. 2009;70(4):326–336.
  • Du W, He J, Zhou W, et al. High IL2RA mRNA expression is an independent adverse prognostic biomarker in core binding factor and intermediate-risk acute myeloid leukemia. J Transl Med. 2019;17(1):1–14.
  • Shen R, Postow MA, Adamow M, et al. LAG-3 expression on peripheral blood cells identifies patients with poorer outcomes after immune checkpoint blockade. Sci Transl Med. 2021;13(608):eabf5107.
  • Knaus HA, Berglund S, Hackl H, et al. Signatures of CD8+ T cell dysfunction in AML patients and their reversibility with response to chemotherapy. JCI Insight. 2018;3(21).
  • Tabata R, Chi SG, Yuda J, et al. Emerging immunotherapy for acute myeloid leukemia. Int J Mol Sci. 2021;22(4):1944.
  • Li L, Cui Y, Shen J, et al. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1. Leuk Res. 2019;78:12–20.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.